Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tai-Chung Tseng

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Clinical and Molecular Hepatology|March 9, 2021
Another oral antiviral treatment, but still far away from hepatitis B virus cureTai-Chung Tseng
Clinical Liver Disease|June 14, 2024
Novel biomarkers for chronic hepatitis B managementTai-Chung Tseng
Clinical and Molecular Hepatology|February 21, 2022
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzlesHung-Yao Lin, Tai-Chung Tseng
Journal of Hepatology|April 5, 2017
HBV markers for HCC prediction: Three heads are better than two?Tai-Chung Tseng, Jia-Horng Kao
Journal of Gastroenterology|October 24, 2012
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dogTai-Chung Tseng, Jia-Horng Kao
Gastroenterology|April 9, 2008
HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzlesTai-Chung Tseng, Jia-Horng Kao
Gastroenterology|March 24, 2009
HBsAg seroclearance: the more and earlier, the betterTai-Chung Tseng, Jia-Horng Kao
Gut and Liver|April 23, 2026
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?Shang-Chin Huang, Tai-Chung Tseng
Clinical and Molecular Hepatology|February 22, 2024
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigenChen-Te Huang, Tai-Chung Tseng
The Journal of Infectious Diseases|November 21, 2017
Immunopathogenesis of Hepatitis B VirusTai-Chung Tseng, Li-Rung Huang
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Clinical and Molecular Hepatology|March 9, 2021
Another oral antiviral treatment, but still far away from hepatitis B virus cureTai-Chung Tseng
Clinical Liver Disease|June 14, 2024
Novel biomarkers for chronic hepatitis B managementTai-Chung Tseng
Clinical and Molecular Hepatology|February 21, 2022
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzlesHung-Yao Lin, Tai-Chung Tseng
Journal of Hepatology|April 5, 2017
HBV markers for HCC prediction: Three heads are better than two?Tai-Chung Tseng, Jia-Horng Kao
Journal of Gastroenterology|October 24, 2012
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dogTai-Chung Tseng, Jia-Horng Kao
Gastroenterology|April 9, 2008
HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzlesTai-Chung Tseng, Jia-Horng Kao
Gastroenterology|March 24, 2009
HBsAg seroclearance: the more and earlier, the betterTai-Chung Tseng, Jia-Horng Kao
Gut and Liver|April 23, 2026
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?Shang-Chin Huang, Tai-Chung Tseng
Clinical and Molecular Hepatology|February 22, 2024
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigenChen-Te Huang, Tai-Chung Tseng
The Journal of Infectious Diseases|November 21, 2017
Immunopathogenesis of Hepatitis B VirusTai-Chung Tseng, Li-Rung Huang
Pageof 19